The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours.

Verslype C, Carton S, Borbath I, Delaunoit T, Demetter P, Demolin G, Hendlisz A, Pattyn P, Pauwels S, Peeters M, Roeyen G, Van Hootegem P, Van Laethem JL, Van Cutsem E. Acta Gastroenterol Belg. 2009 Jan-Mar;72(1):54-8. Review.

Voir l’article

← Retour aux publications